thiamorpholine has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekka, EA; Theodosis-Nobelos, P; Tooulia, KK | 1 |
| Gavalas, A; Kourti, M; Rekka, EA; Theodosis-Nobelos, P | 1 |
2 other study(ies) available for thiamorpholine and Hyperlipidemias
| Article | Year |
|---|---|
Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Biomarkers; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hyperlipidemias; Lipid Peroxidation; Lipoproteins, LDL; Molecular Structure; Morpholines; Polyethylene Glycols; Rats; Structure-Activity Relationship; Triglycerides | 2015 |
Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholesterol; Cholesterol, LDL; Edema; Hyperlipidemias; Hypolipidemic Agents; Morpholines; Rats; Triglycerides | 2016 |